NASDAQ$GOCO
GoHealth Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Announced second quarter 2022 results, with a decrease in net revenue and an increase in medicare submitted policies.
GoHealth reported a decrease in net revenue by 19% compared to the prior year period, totaling $158.7 million. The company experienced a net loss of $113.8 million, a significant increase from the previous year's $39.2 million loss. However, Medicare Submitted Policies increased by 9% compared to the prior year period, reaching 177,911.
- Medicare Submitted Policies increased 9% compared to the prior year period.
- Net revenue decreased 19% compared to the prior year period.
- Net loss significantly increased compared to the prior year period.
- Adjusted EBITDA decreased compared to the prior year period.
Headline financials
Revenue & EPS history
GoHealth · Revenue · Quarterly
$159M
Revenue by segment
GoHealth · $11.9M total across 4 segments · Q1 2026
- Medicare Agency Revenue$9.8M—82.2%
- Other Non-Agency Revenue$1.76M—14.8%
- Medicare Non-Agency Revenue$200K—1.7%
- Other Agency Revenue$155K—1.3%
Forward guidance
GoHealth has suspended the Company’s previously issued quantitative guidance for the remainder of 2022 and expects to achieve cash flow breakeven on a trailing twelve-month basis by the middle of next year.
Tailwinds
- Renewed focus on high-quality customer experience.
- Efficiency improvements.
- Focus on cash flow.
- Strategic moves, including cost actions, to strengthen ability to achieve cash flow breakeven.
- Ramping up Encompass programs to be fully deployed for the upcoming AEP.
Headwinds
- Suspension of previously issued quantitative guidance for the remainder of 2022.
- Competitive dynamics amongst carrier partners.
- Evolving needs of Medicare beneficiaries.
- This quarter’s results do not represent the financial performance they are capable of achieving.
- facing a natural inflection point
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2022
-7.7%
Avg return
Earnings day
-9.7%
Avg return
5 days after
-6.6%
Avg return
30 days after
26%
6 / 23 earnings
Positive
+32.2%
Q1 2023
Best reaction
-45.5%
Q2 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.5% | -23.4% | — | |
| Q3 2025 | -24.4% | -32.0% | -12.8% | |
| Q2 2025 | -9.0% | -7.6% | -23.8% | |
| Q1 2025 | -0.6% | -17.4% | -21.4% | |
| Q4 2024 | -14.4% | -14.9% | -32.8% | |
| Q3 2024 | -6.6% | -0.4% | -15.4% | |
| Q2 2024 | -21.4% | -28.3% | -34.0% | |
| Q1 2024 | -8.0% | -11.1% | +2.2% | |
| Q4 2023 | -13.0% | -25.7% | -27.0% | |
| Q3 2023 | +2.3% | +6.7% | +7.4% | |
| Q2 2023 | +6.8% | +6.3% | -17.2% | |
| Q1 2023 | +32.2% | +44.8% | +99.5% | |
| Q4 2022 | -19.9% | -6.2% | -18.5% | |
| Q3 2022 | -16.7% | -9.4% | +95.3% | |
| Q2 2022 | -31.5% | -43.3% | -57.0% | |
| Q1 2022 | +11.1% | +4.9% | +6.5% | |
| Q4 2021 | +23.7% | +37.7% | -9.8% | |
| Q3 2021 | +1.1% | -4.7% | -18.1% | |
| Q2 2021 | -45.5% | -42.2% | -34.7% | |
| Q1 2021 | -2.7% | -5.6% | -4.0% | |
| Q4 2020 | -14.9% | -16.9% | -4.1% | |
| Q3 2020 | -14.9% | -15.1% | +1.8% | |
| Q2 2020 | -10.5% | -18.5% | -27.1% | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro